Skip to main content
SpringerLink
Log in

Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled sitespecific delivery of acidic anti-inflammatory active ingredient

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of the investigation was to evaluate the potential of polyamidoamine (PAMAM) dendrimer as nanoscale drug delivery units for controlled release of water insoluble and acidic anti-inflammatory drug. Flurbiprofen (FB) was selected as a model acidic anti-inflammatory drug. The aqueous solutions of 4.0 generation (G) PAMAM dendrimer in different concentrations were prepared and used further for solubilizing FB. Formation of dendrimer complex was characterized by Fourier transform infrared spectroscopy. The effect of pH on the solubility of FB in dendrimer was evaluated. Dendrimer formulations were further evaluated for in vitro release study and hemolytic toxicity. Pharmacokinetic and biodistribution were studied in male albino rats. Efficacy of dendrimer formulation was tested by carrageenan induced paw edema model. It was observed that the loaded drug displayed initial rapid release (more than 40% till 3rd hour) followed by rather slow release. Pharmacodynamic study revealed 75% inhibition at 4th hour that was maintained above 50% till 8th hour. The mean residence time (MRT) and terminal half-life (THF) of the dendritic formulation increased by 2-fold and 3-fold, respectively, compared with free drug. Hence, with dendritic system the drug is retained for longer duration in the biosystem with 5-fold greater distribution. It may be concluded that the drug-loaded dendrimers not only enhanced the solubility but also controlled the delivery of the bioactive with localized action at the site of inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beezer AE, King ASH, Martin IK, Mitchel JC, Twyman LJ, Wain CF. Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives.Tetrahedron. 2003;59:3873–3880.

    Article  CAS  Google Scholar 

  2. Patri AK Jr, Majoros IJ Jr, Baker JR Jr. Dendritic polymer macromolecular carriers for drug delivery.Curr Opin Chem Biol. 2002;6:466–471.

    Article  CAS  Google Scholar 

  3. Bosman AW, Janssen HM, Meijer EW. About dendrimers: structure, physical properties, and applications.Chem Rev. 1999;99:1665–1688.

    Article  CAS  Google Scholar 

  4. Milhem OM, Myles C, McKeown NB, Attwood D, Emanuele AD. Polyamidoamine starburst dendrimers as solubility enhancers.Int J Pharm. 2000;197:239–241.

    Article  CAS  Google Scholar 

  5. Kolhe P, Misra E, Kannan RM, Kannan S, Lieh-Lai M. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.Int J Pharm. 2003;259:143–160.

    Article  CAS  Google Scholar 

  6. Zeng F, Zimmerman SC. Dendrimers in supramolecular chemistry: from molecular recognition to self-assembly.Chem Rev. 1997; 97:1681–1712.

    Article  CAS  Google Scholar 

  7. Chauhan AS, Sridevi S, Chalasani KB, et al. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.J Control Release. 2003;90:335–343.

    Article  CAS  Google Scholar 

  8. Khopade AJ, Caruso F, Tripathi P, Nagaich S, Jain NK. Effect of dendrimer on entrapment and release of bioactive from liposomes.Int J Pharm. 2002;232:157–162.

    Article  CAS  Google Scholar 

  9. Khopade AJ, Shenoy DB, Khopade SA, Jain NK. Phase structures of a hydrogenated anionic phospholipid composition containing cationic dendrimers and pegylated lipids.Langmuir. 2004;20:7368–7373.

    Article  CAS  Google Scholar 

  10. Park KM, Kim CK. Preparation and evaluation of flurbiprofenloaded microemulsion for parenteral delivery.Int J Pharm. 1999;181:173–179.

    Article  CAS  Google Scholar 

  11. Park KM, Lee MK, Hwang KJ, Kim CK. Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process.Int J Pharm. 1999;183:145–154.

    Article  CAS  Google Scholar 

  12. Government of India.Indian Pharmacopoeia. New Delhi, India: Ministry of Health and Family Welfare, Controller of Publications; 1996:328.

    Google Scholar 

  13. Singhai AK, Jain S, Jain NK. Evaluation of an aqueous injection of ketoprofen.Pharmazie. 1997;52:149–151.

    CAS  Google Scholar 

  14. Chauhan AS, Jain NK, Diwan PV, Khopade AJ. Solubility enhancement of indomethacin with poly(amidoamine) dendrimers and targeting to inflammatory regions of arthritic rats.J Drug Target. 2004;12:575–583.

    Article  CAS  Google Scholar 

  15. Bhadra D, Bhadra S, Jain S, Jain NKA. PEGylated dendritic nanoparticulate carrier of fluorouracil.Int J Pharm. 2003;257:111–124.

    Article  CAS  Google Scholar 

  16. Hardman JG, Limbird LE, Molinoff PB, Ruddeon RW, Gilman AG.Goodman and Gilman's the Pharmacological Basis of Therapeutics, Vol 9. New York, NY: McGraw-Hill; 1996:640–647.

    Google Scholar 

  17. Kissel M, Peschke P, Subr V, et al. Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors.PDA J Pharm Sci Technol. 2001;55:191–201.

    CAS  Google Scholar 

  18. Crommelin DJA, Hennik WE, Strom G. Drug targeting systems: fundamentals and applications to parenteral drug delivery. In: Hillery AM, Lloyd AW, Swarbrick J, eds.Drug Delivery and Targeting. New York, NY: Taylor and Francis Inc; 2001:119–125.

    Google Scholar 

  19. Klajnert B, Stanislawska L, Bryszewska M, Palecz B. Interactions between PAMAM dendrimers and bovine serum albumin.Biochim Biophys Acta. 2003;1648:115–126.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, Dr. H. S. Gour University, 470 003, Sagar, India

    Abhay Asthana & Narendra Kumar Jain

  2. Pharmacology Division, Indian Institute of Chemical Technology, Habsiguda, 500 007, Tarnaka, Hyderabad, India

    Abhay Singh Chauhan & Prakash Vamanrao Diwan

Authors
  1. Abhay Asthana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhay Singh Chauhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prakash Vamanrao Diwan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Narendra Kumar Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Narendra Kumar Jain.

Additional information

Published: October 27, 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asthana, A., Chauhan, A.S., Diwan, P.V. et al. Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled sitespecific delivery of acidic anti-inflammatory active ingredient. AAPS PharmSciTech 6, 67 (2005). https://doi.org/10.1208/pt060367

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt060367

Keywords

Search

Navigation